Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors

Ching Chuan Kuo, Tsang Wu, Li Tzong Chen, Her Shyong Shiah, Ching Ming Wu, Yen Ting Cheng, Wen Yu Pan, Jin Fen Liu, Kuo Li Chen, Yun Ning Yang, Shan Na Chen, Jang Yang Chang

研究成果: 雜誌貢獻文章同行評審

7 引文 斯高帕斯(Scopus)


Arsenic trioxide (As 2O 3) is an effective treatment for relapsed or refractory acute promyelocytic leukemia (APL). After the discovery of As 2O 3 as a promising treatment for APL, several studies investigated the use of As 2O 3 as a single agent in the treatment of solid tumors; however, its therapeutic efficacy is limited. Thus, the systematic study of the combination of As 2O 3 with other clinically used chemotherapeutic drugs to improve its therapeutic efficacy in treating human solid tumors is merited. In this study, we demonstrate for the first time, using isobologram analysis, that As 2O 3 exhibits a synergistic interaction with N,N′-bis(2-chloroethyl)-N-nitrosourea (BCNU). The synergistic augmentation of the cytotoxicity of As 2O 3 with BCNU is in part through the autophagic cell death machinery in human solid tumor cells. As 2O 3 and BCNU in combination produce enhanced cytotoxicity via the depletion of reduced glutathione (GSH) and augmentation of reaction oxygen species (ROS) production. Further analysis indicated that the extension of GSH depletion by this combined regimen occurs through the inhibition of the catalytic activity of glutathione reductase. Blocking ROS production with antioxidants or ROS scavengers effectively inhibits cell death and autophagy formation, indicating that redox-mediated autophagic cell death involves the synergism of As 2O 3 with BCNU. Taken together, this is the first evidence that BCNU could help to extend the therapeutic spectrum of As 2O 3. These findings will be useful in designing future clinical trials of combination chemotherapy with As 2O 3 and BCNU, with the potential for broad use against a variety of solid tumors.
頁(從 - 到)2195-2209
期刊Free Radical Biology and Medicine
出版狀態已發佈 - 12月 15 2011

ASJC Scopus subject areas

  • 生物化學
  • 生理學(醫學)


深入研究「Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors」主題。共同形成了獨特的指紋。